UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049246
Receipt number R000056017
Scientific Title Creating a visual stimulator using a head-mounted display (HMD)
Date of disclosure of the study information 2022/10/18
Last modified on 2022/10/18 15:25:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Creating a visual stimulator

Acronym

Creating a visual stimulator

Scientific Title

Creating a visual stimulator using a head-mounted display (HMD)

Scientific Title:Acronym

Creating a visual stimulator using HMD

Region

Japan


Condition

Condition

Vestibular disorder

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Seasickness and virtual reality sickness are known to cause equilibrium dysfunction due to a "mismatch" between somatosensory (mainly through skin and muscle sensation) and visual sensations, but it is known to become accustomed (adaptation). Responses adapted by somatosensory or visual sensations are referred to as adaptive phenomena, which we examined using rotation testing and a flat and spherical screen with projected black and white stripes, as well as visual vestibular inconsistency stimulation. The results of our previous studies showed that a flat screen under off-vertical axis rotation (OVAR) and a spherical screen under earth vertical axis rotation (EVAR) were suitable for visual vestibular inconsistency stimulation. Visual stimulation of linear motion was suitable for otolith-ocular reflex (OOR) and visual stimulation of rotational angular rate motion for semicircular canal-ocular reflex (ScOR).
The purpose of this study is to reaffirm previous research by using computer graphic techniques to perform pseudo-linear and pseudo-rotational visual stimuli. The eventual goal is to obtain the basic data necessary to appropriately select the modality of visual stimulation to be used during rehabilitation, depending on the site of the disorder, in cases where the semicircular canal is impaired or the otolith is impaired.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

Using the created HMD, perform pseudo-linear and pseudo-rotational visual stimulation on the subject. Subjects will be asked to complete a questionnaire immediately following the study. Evaluate the validity of the stimuli by asking the participants to describe whether they feel as if they moved reality in a straight line when they experienced the pseudo-linear visual stimuli, and whether they feel as if they rotated reality when they experienced the pseudo-rotational visual stimuli ("felt", "felt a little", or "did not feel").

Key secondary outcomes

Using the created HMD, perform pseudo-linear and pseudo-rotational visual stimulation on the subject. Subjects will be asked to complete a questionnaire immediately following the study. The participants will be asked to describe whether nausea or other symptoms appeared during the test ("felt", "felt a little", or "did not feel") to evaluate safety.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The participants will wear a head-mounted display (HMD).
Pseudo-linear and pseudo-rotational visual stimuli are added on the HMD, and the visibility is verified by a questionnaire method. The test time is approximately 30 minutes. The test will be conducted only once per subject.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy subjects who do not have an equilibrium disorder and who have given their free and voluntary written consent to participate in this study, after having demonstrated sufficient understanding of the study after the explanation of the study.

Key exclusion criteria

Cases in which consent was not obtained, and other cases in which participation in the study was deemed impossible due to medical conditions or physical condition.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Izumi
Middle name
Last name Koizuka

Organization

St. Marianna University School of Medicine

Division name

Otorhinolaryngology

Zip code

216-8511

Address

2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511 Japan

TEL

044-977-8111(ext.3261)

Email

koizuka@marianna-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Ito

Organization

St. Marianna University School of Medicine

Division name

Otorhinolaryngology

Zip code

216-8511

Address

2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511 Japan

TEL

044-977-8111(ext.3261)

Homepage URL


Email

yusuke.ito@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and
Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagashima Medical Instruments.Co.,Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

St. Marianna University School of Medicine

Address

2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511 Japan

Tel

044-977-8111

Email

k-sienbu.mail@marianna-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 07 Month 12 Day

Date of IRB


Anticipated trial start date

2022 Year 10 Month 18 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 18 Day

Last modified on

2022 Year 10 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056017


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name